| Company Name: |
BOC Sciences |
| Tel: |
16314854226; +8616314854226 |
| Email: |
inquiry@bocsci.com |
4-Quinolone-3-Carboxamide Furan CB2 Agonist manufacturers
|
| | 4-Quinolone-3-Carboxamide Furan CB2 Agonist Basic information |
| Product Name: | 4-Quinolone-3-Carboxamide Furan CB2 Agonist | | Synonyms: | 4-Quinolone-3-Carboxamide Furan CB2 Agonist;N-(1-adamantyl)-6-(furan-2-yl)-8-methoxy-4-oxo-1-pentylquinoline-3-carboxamide;3-Quinolinecarboxamide, 6-(2-furanyl)-1,4-dihydro-8-methoxy-4-oxo-1-pentyl-N-tricyclo[3.3.1.13,7]dec-1-yl-;CB2 receptor agonist 2 | | CAS: | 1314230-75-5 | | MF: | C30H36N2O4 | | MW: | 488.62 | | EINECS: | | | Product Categories: | | | Mol File: | 1314230-75-5.mol |  |
| | 4-Quinolone-3-Carboxamide Furan CB2 Agonist Chemical Properties |
| storage temp. | Store at -20°C | | solubility | ≤30mg/ml in ethanol;3mg/ml in DMSO;3mg/ml in dimethyl formamide | | form | crystalline solid | | color | White to light yellow |
| | 4-Quinolone-3-Carboxamide Furan CB2 Agonist Usage And Synthesis |
| Uses | CB2 receptor agonist 2 is a potent and selective agonist for the CB2 (cannabinoid type 2) receptor with a Ki of 8.5 nM. CB2 receptor agonist 2 has high affinity and selectivity for CB2[1]. | | Biological Activity | ki: 8.5 nm4-quinolone-3-carboxamide furan cb2 agonist is a high-affinity ligand of cb2.the endocannabinoid system consists of endogenous cannabinoids (endocannabinoids), cannabinoid receptors (primarily cb1 and cb2), and the enzymes that synthesize and degrade endocannabinoids. | | in vitro | previous study found that 4-quinolone-3-carboxamide furan cb2 agonist (4g) was devoid of any potential “indirect” agonist activity at cannabinoid receptors, exerted by prolonging the lifespan of endocannabinoids because 4g at up to a 10 μm concentration did not inhibit anandamide or 2-ag degradation by faah or magl, respectively. in cytotosicity study, 4g was tested at 1 μm and the results showed that it exhibited very low or no cytotoxicity, the cell viability being above 95% after a 72 h treatment [1]. | | in vivo | in animal study, 4g was found to have antinociceptive activity in the formalin test in mice. moreover, 4g was very potent with maximal effect being reached at the 1 mg/kg dose and efficacious also on the first phase of the nocifensive response. the effect of 4g could be strongly reduced by the addition of am630, a cb2-selective antagonist/inverse agonist, therefore demonstrating that 4g might act as a potent and selective cb2 agonist [1]. | | IC 50 | CB2: 8.5 nM (Ki) | | references | [1] s. pasquini, m. de rosa, v. pedani, et al. investigations on the 4-quinolone-3-carboxylic acid motif. 4. identification of new potent and selective ligands for the cannabinoid type 2 receptor with diverse substitution patterns and antihyperalgesic effects in mice. journal of medicinal chemistry 54, 5444-5453 (2011). |
| | 4-Quinolone-3-Carboxamide Furan CB2 Agonist Preparation Products And Raw materials |
|